Table 2.

Fisher’s exact test p-value and odds ratio (OR) for determining prevalence of overall H. pylori and CagA-positive H. pylori infection in patients with AITDs and controls.

HP+ vs. HP−	Significance (p)	OR (95% CI)
GD vs. Controls	p < 0.001	4.8 (2.32–9.95)
HT vs. Controls	p < 0.001	4.36 (2.43–7.8)
GD vs. AT	p < 0.01	3.87 (1.57–9.51)
HT vs. AT	p < 0.001	3.51 (1.63–7.57)
HP+/CagA+ vs. HP+/CagA−	Significance (p)	OR (95% CI)
GD vs. Controls	p < 0.05	3.43 (1.17–10.07)
HT vs. Controls	p < 0.01	3.54 (1.38–9.05)